#外资研报

图片

无图片

正文

无正文

总体总结

暂无总结

文档

GS-联想(0992.HK):AI驱动增长,目标价上调至27港元,维持买入 Lenovo (0992.HK) AI to drive growth ahead; TP up to HK$27; Buy.pdf

预览

GS-联想(0992.HK):AI驱动增长,目标价上调至27港元,维持买入 Lenovo (0992.HK) AI to drive growth ahead; TP up to HK$27; Buy.pdf

GS-美股市场观点:盈利增长之路崎岖,高收益并非坦途 US EQUITY VIEWS Earnings growth paves a bumpy path to higher returns.pdf

预览

GS-美股市场观点:盈利增长之路崎岖,高收益并非坦途 US EQUITY VIEWS Earnings growth paves a bumpy path to higher returns.pdf

GS-盛美半导体(ACMR.US):升级设备受益于先进逻辑与存储芯片扩张;差异化技术新品放量;维持买入评级 ACM Research (ACMR) Enhanced tools riding on advanced logic_memory expansion; New products with differentiated technology; Buy.pdf

预览

GS-盛美半导体(ACMR.US):升级设备受益于先进逻辑与存储芯片扩张;差异化技术新品放量;维持买入评级 ACM Research (ACMR) Enhanced tools riding on advanced logic_memory expansion; New products with differentiated technology; Buy.pdf

GS-亚洲指数策略:恒生指数调整回顾与资金流向影响(2026年6月) Hang Seng Indexes Rebalancing Review and Flow Implications(June 2026)-20260524.pdf

预览

GS-亚洲指数策略:恒生指数调整回顾与资金流向影响(2026年6月) Hang Seng Indexes Rebalancing Review and Flow Implications(June 2026)-20260524.pdf

GS-中国4月工业利润收入双升及PMI预览-20260527.pdf

预览

GS-中国4月工业利润收入双升及PMI预览-20260527.pdf

GS-中国宏观:近期三大核心观察 China:Three things in China.pdf

预览

GS-中国宏观:近期三大核心观察 China:Three things in China.pdf

GS-华测导航(300627.SZ):中国科技:面向精准农业、智能驾驶、机器人领域高精度服务的卫星信号接收机 GC Tech:Huace Navigation(300627.SZ):Satellite signal receivers for high-precision services in Precision Agriculture,-20260523.pdf

预览

GS-华测导航(300627.SZ):中国科技:面向精准农业、智能驾驶、机器人领域高精度服务的卫星信号接收机 GC Tech:Huace Navigation(300627.SZ):Satellite signal receivers for high-precision services in Precision Agriculture,-20260523.pdf

GS-珂玛科技(301611.SZ):管理层交流纪要——半导体陶瓷零部件受益行业增长与国产化趋势 Kematek (301611.SZ):Mgmt. visit:Ceramic semis component to ride on market growth and localization trend.pdf

预览

GS-珂玛科技(301611.SZ):管理层交流纪要——半导体陶瓷零部件受益行业增长与国产化趋势 Kematek (301611.SZ):Mgmt. visit:Ceramic semis component to ride on market growth and localization trend.pdf

GS-科伦药业(002422.SZ):一线PD-L1阳性非小细胞肺癌sac-TMT联合方案生存获益强劲,维持买入评级 Sichuan Kelun Pharmaceutical Co.(002422.SZ):Strong survival benefit of sac-TMTpembro combo in 1L PD-L1 positive NSCLC-20260522.pdf

预览

GS-科伦药业(002422.SZ):一线PD-L1阳性非小细胞肺癌sac-TMT联合方案生存获益强劲,维持买入评级 Sichuan Kelun Pharmaceutical Co.(002422.SZ):Strong survival benefit of sac-TMTpembro combo in 1L PD-L1 positive NSCLC-20260522.pdf